Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review

Bibliographic Details
Title: Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review
Authors: Francesco Blasi, Stefano Aliberti, Antonio Voza, Gabriele Bongiovanni, Antonio Tonutti, Anna Stainer, Mattia Nigro, Dean L Kellogg, Anoop Nambiar, Andrea Gramegna, Marco Mantero, Francesco Amati
Source: BMJ Open Respiratory Research, Vol 11, Iss 1 (2024)
Publisher Information: BMJ Publishing Group, 2024.
Publication Year: 2024
Collection: LCC:Medicine
LCC:Diseases of the respiratory system
Subject Terms: Medicine, Diseases of the respiratory system, RC705-779
More Details: Objectives Vasoactive drugs have exhibited clinical efficacy in addressing pulmonary arterial hypertension, manifesting a significant reduction in morbidity and mortality. Pulmonary hypertension may complicate advanced interstitial lung disease (PH-ILD) and is associated with high rates of disability, hospitalisation due to cardiac and respiratory illnesses, and mortality. Prior management hinged on treating the underlying lung disease and comorbidities. However, the INCREASE trial of inhaled treprostinil in PH-ILD has demonstrated that PH-ILD can be effectively treated with vasoactive drugs.Methods This comprehensive systematic review examines the evidence for vasoactive drugs in the management of PH-ILD.Results A total of 1442 pubblications were screened, 11 RCTs were considered for quantitative synthesis. Unfortunately, the salient studies are limited by population heterogeneity, short-term follow-up and the selection of outcomes with uncertain clinical significance.Conclusions This systematic review underscores the necessity of establishing a precision medicine-oriented strategy, directed at uncovering and addressing the intricate cellular and molecular mechanisms that underlie the pathophysiology of PH-ILD.PROSPERO registration number CRD42023457482.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2052-4439
Relation: https://bmjopenrespres.bmj.com/content/11/1/e002161.full; https://doaj.org/toc/2052-4439
DOI: 10.1136/bmjresp-2023-002161
Access URL: https://doaj.org/article/83888c04e1cb47bc9c942bccd30079d7
Accession Number: edsdoj.83888c04e1cb47bc9c942bccd30079d7
Database: Directory of Open Access Journals
More Details
ISSN:20524439
DOI:10.1136/bmjresp-2023-002161
Published in:BMJ Open Respiratory Research
Language:English